CRISPR-based Phage Therapy Shines in the First Human Trial
SNIPR Biome, a Danish microbiome technology company, has unveiled promising results from the...
Revolutionizing Infection Treatment: SNIPR Biome’s CRISPR-armed Phage Therapy Targets Antibiotic-Resistant E. Coli in Gut
SNIPR Biome ApS has made a groundbreaking discovery in the field of microbiology, paving the way for a new era of microbial gene therapy....
